≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback
info icon

Malignant neoplasm of uterus, part unspecified, excluding all cancers (controls excluding all cancers)

Endpoint Browser

C3_UTERUS_NAS_EXALLC

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

only females

293373

2. Check conditions

None

293373

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — C55
  • Hospital discharge: ICD-8 — 182
  • Cause of death: ICD-10 — C55
  • Cause of death: ICD-8 — 182
  • Cause of death: excluded ICD-8 — 1820
  • Cancer registry: Topography ICD-O-3 — C55
  • Cancer registry: Morphology ICD-O-3 — ANY
  • Cancer registry: Behaviour codes — 3

3 out of 7 registries used, show all original rules.

167

4. Check minimum number of events

None

167

5. Include endpoints

None

167

6. Filter based on genotype QC (FinnGen only)

167

Control definitions (FinnGen only)

Control exclude
C3_CANCER, C3_CANCER_WIDE_EXALLC

Extra metadata

First used in FinnGen datafreeze
DF12

Similar endpoints

↥

List of similar endpoints to Malignant neoplasm of uterus, part unspecified, excluding all cancers (controls excluding all cancers) based on the number of shared cases.

Venn diagram with an highlighted set fully inside another set Similar with more cases:

Venn diagram with a set fully inside an highlighted set Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 167 167 -
Unadjusted period prevalence (%) 0.06 0.06 -
Median age at first event (years) 54.73 54.73 -

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

No data available

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
34
48
8.64
23.86
4.8
1.5
u/ml
92.6
37.6
0.60
34
48
(4035726)
21
17
13.99
21.60
1.8
1.2
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
68
332
2.77
9.04
2.2
1.7
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
13
22
6.32
7.50
1.4
1.4
pmol/l
183.4
87.3
0.46
13
22
(3013650) Neutrophils [#/volume] in Blood by Automated count
93
597
2.26
6.22
9.6
4.9
e9/l
4.6
4.4
0.14
78
500
(4281824)
10
8
13.19
6.16
1.1
1.0
—
—
—
0
0
(40758558) Short blood count panel - Blood
50
257
2.35
5.58
9.4
4.1
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
56
310
2.21
5.20
2.5
2.1
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
23
85
2.98
4.92
1.5
1.6
g/l
0.2
0.2
0.60
23
77
(3024561) Albumin [Mass/volume] in Serum or Plasma
83
559
1.96
4.40
5.8
3.1
g/l
33.4
34.7
1.34
74
506
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
68
441
1.91
3.93
3.4
3.3
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
70
468
1.85
3.62
5.0
3.8
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
40
223
2.04
3.52
2.5
2.0
—
—
—
0
0
(3002256) Pathology report gross observation
17
65
2.80
3.42
1.2
1.1
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
52
322
1.89
3.38
4.6
3.7
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
37
206
2.02
3.25
2.8
3.1
e6/l
4.8
5.0
0.05
22
104
(3019069) Monocytes/100 leukocytes in Blood
73
510
1.77
3.17
5.0
5.0
%
8.6
8.5
0.11
64
462
(3002030) Lymphocytes/100 leukocytes in Blood
74
520
1.76
3.15
5.0
4.8
%
22.1
26.6
2.09
64
465
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
29
150
2.13
3.09
3.6
2.2
%
21.2
20.9
0.03
23
129
(3018010) Neutrophils/100 leukocytes in Blood
73
514
1.75
3.06
4.6
4.7
%
62.7
58.5
1.68
62
463
(3035320) C reactive protein [Mass/volume] in Body fluid
5
5
10.25
3.00
2.6
3.8
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
72
508
1.73
2.98
4.9
4.7
%
2.3
2.8
1.22
62
457
(3002582) Erythrocytes [#/volume] in Urine
58
387
1.76
2.91
3.6
3.3
e6/l
44.0
45.6
0.02
43
288
(3022096) Basophils/100 leukocytes in Blood
69
490
1.70
2.74
5.1
4.6
%
0.7
0.7
0.06
59
437
(3013115) Eosinophils [#/volume] in Blood
77
564
1.68
2.72
5.0
4.4
e9/l
0.2
0.2
0.57
63
477
(3015377) Calcium [Moles/volume] in Serum or Plasma
64
450
1.68
2.62
4.0
2.0
mmol/l
2.4
2.4
0.01
53
371
(3018095) Leukocytes [#/volume] in Urine
64
451
1.68
2.59
4.5
4.0
e6/l
159.9
174.6
0.08
47
308
(3014007) Fractional oxyhemoglobin in Arterial blood
15
63
2.52
2.54
3.7
4.0
%
95.6
94.4
0.92
15
63
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
78
582
1.64
2.51
6.2
4.0
mmol/l
1.2
1.2
0.09
71
516
(3017143) Hepatitis C virus Ab [Presence] in Serum
13
51
2.68
2.51
1.4
1.3
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
51
341
1.71
2.49
3.4
3.2
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
85
650
1.63
2.47
6.9
4.5
mmol/l
1.2
1.2
0.00
73
557
(3022948) Iron [Moles/volume] in Serum or Plasma
31
180
1.89
2.40
3.0
2.1
umol/l
12.4
12.1
0.06
26
161
(3001604) Monocytes [#/volume] in Blood
73
544
1.61
2.32
5.0
4.4
e9/l
0.6
0.6
0.11
60
449
(3006315) Basophils [#/volume] in Blood
73
547
1.59
2.25
5.0
4.4
e9/l
0.0
0.0
0.15
60
450
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
19
95
2.13
2.21
1.7
1.7
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
74
559
1.58
2.19
5.1
4.4
e9/l
3.7
1.8
0.40
59
471
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
29
170
1.85
2.18
1.6
1.3
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
35
218
1.77
2.17
2.4
2.8
e6/l
0.8
1.6
1.83
21
114
(3000991) Gas panel - Venous blood
19
96
2.10
2.15
5.7
4.2
—
—
—
0
0
(3000492) Spirometry study
14
63
2.33
2.07
1.2
1.6
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
13
57
2.39
2.03
1.5
1.3
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
50
352
1.60
1.96
5.3
4.6
—
—
—
0
0
(40768443) Skin Pathology biopsy report
11
46
2.49
1.89
1.3
1.2
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
105
883
1.51
1.77
8.1
4.7
u/l
81.6
78.2
0.54
99
793
(3030467) Casts [#/volume] in Urine by Automated count
49
355
1.54
1.68
3.4
3.2
e6/l
0.1
0.6
3.14
36
265
(3003396) Base excess in Arterial blood by calculation
24
147
1.74
1.58
3.8
3.8
mmol/l
2.0
1.7
0.14
19
109
(3032080) INR in Blood by Coagulation assay
67
525
1.46
1.56
4.5
10.0
inr
1.4
1.3
0.10
18
146
(3018418) pH of Serum or Plasma
53
397
1.49
1.54
5.1
3.0
ph
7.4
7.4
—
8
61
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
42
301
1.53
1.50
4.2
2.4
mmol/l
2.5
2.5
1.95
35
256
(3000494) Fungus identified in Specimen by Culture
22
134
1.74
1.48
1.6
1.4
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
70
560
1.43
1.44
4.6
3.9
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
12
60
2.08
1.42
6.0
5.5
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
14
75
1.95
1.39
1.6
1.3
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
6
23
2.67
1.38
3.2
1.3
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
6
23
2.67
1.38
1.3
2.3
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
85
715
1.38
1.27
4.2
3.6
mmol/l
6.8
6.9
0.04
80
654
(3042936) Bacteria identified in Isolate by Culture
24
158
1.61
1.23
2.0
1.8
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
10
50
2.06
1.19
1.0
1.2
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
45
343
1.43
1.18
2.2
2.4
mg/l
2.4
3.4
3.74
36
285
(3051387) C reactive protein [Mass/volume] in Capillary blood
0
35
0.00
1.16
0.0
4.1
—
30.8
—
0
21
(3002032) Base excess in Venous blood by calculation
21
137
1.61
1.12
4.6
3.0
mmol/l
0.7
2.8
1.01
16
113
(3026782) Osmolality of Urine
37
275
1.44
1.10
4.2
2.8
mosm/kgh2o
472.6
516.5
0.61
29
229
(3021879) Hepatitis B virus core Ab [Presence] in Serum
7
34
2.10
1.04
1.0
1.2
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
31
227
1.45
1.00
1.5
1.2
—
—
—
0
0
(3019060) Gas panel - Arterial blood
13
77
1.75
0.98
3.1
3.9
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
7
36
1.98
0.98
2.3
1.5
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
7
36
1.98
0.98
1.1
1.2
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
7
37
1.93
0.95
3.6
4.0
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
40
311
1.38
0.93
4.6
4.3
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
19
128
1.55
0.91
1.8
1.8
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
59
490
1.32
0.89
9.8
8.0
e9/l
0.0
0.0
0.44
48
389
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
30
224
1.41
0.88
1.7
1.7
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
71
606
1.30
0.88
2.2
2.1
pmol/l
89.7
95.0
0.42
39
261
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
13
80
1.68
0.87
1.4
1.4
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
22
155
1.48
0.86
1.5
1.2
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
8
46
1.78
0.84
1.1
1.2
—
—
—
0
0
(3020891) Body temperature
8
46
1.78
0.84
3.6
3.5
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
35
274
1.35
0.78
3.3
2.6
e6/l
6.6
7.3
0.20
29
234
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
0
27
0.00
0.78
0.0
2.1
—
1.7
—
0
19
(3001019) Free T4 and TSH panel - Serum or Plasma
0
27
0.00
0.78
0.0
1.6
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
21
150
1.46
0.78
1.6
2.3
%
1.9
1.8
0.51
15
135
(3007164) IgA [Mass/volume] in Serum or Plasma
25
185
1.41
0.78
1.6
1.2
g/l
2.4
2.4
0.06
11
95
(1002224) Polysomnography panel
0
28
0.00
0.77
0.0
1.1
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
19
134
1.47
0.75
2.9
3.3
—
—
—
0
0
(3008898) HLA-B27 [Presence]
5
24
2.12
0.75
1.0
1.2
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
7
38
1.88
0.74
2.4
2.7
mmol/l
3.6
3.9
—
7
33
(3012544) pH of Venous blood
20
143
1.45
0.74
4.4
3.1
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
21
153
1.43
0.71
13.7
8.8
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
97
877
1.25
0.71
6.2
5.2
—
—
—
0
0
(3022621) pH of Urine by Test strip
5
93
0.52
0.69
4.8
3.4
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
5
27
1.88
0.69
1.8
1.1
—
—
—
0
0
(3015736) pH of Urine
60
516
1.25
0.67
4.8
4.5
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
5
28
1.81
0.66
1.0
1.4
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
5
28
1.81
0.66
3.6
1.9
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
40
330
1.28
0.63
2.0
1.7
nmol/l
1066.5
1225.4
0.64
28
249
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
88
963
0.82
0.61
4.5
4.1
pmol/l
15.3
15.1
0.31
77
859
(3044941) Cell count panel - Synovial fluid
0
22
0.00
0.60
0.0
1.8
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
16
115
1.43
0.59
4.6
2.7
ng/l
138.5
87.0
—
10
97
(3001122) Ferritin [Mass/volume] in Serum or Plasma
56
485
1.23
0.58
3.5
2.7
ug/l
254.5
91.6
1.56
50
431
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
18
133
1.40
0.58
1.8
2.5
ug/l
2.8
3.7
0.67
13
115
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
6
36
1.69
0.57
1.0
1.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
6
36
1.69
0.57
1.0
1.4
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
9
59
1.55
0.56
1.0
1.1
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
28
225
1.29
0.54
1.2
1.3
u/ml
0.7
1.0
—
6
53
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
62
547
1.21
0.54
2.1
2.3
nmol/l
79.3
80.6
0.14
54
472
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
22
171
1.33
0.53
1.5
1.7
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
18
136
1.36
0.52
1.2
1.3
titre
234.3
728.2
—
7
39
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
22
172
1.32
0.51
1.4
1.7
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
7
45
1.58
0.49
1.6
1.1
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
11
76
1.48
0.49
1.1
1.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
7
48
1.48
0.47
1.1
1.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
7
48
1.48
0.47
1.1
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
7
49
1.45
0.46
1.1
1.2
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
12
86
1.43
0.46
2.4
2.6
—
—
—
0
0
(40761535) Cells panel - Urine sediment
14
104
1.38
0.45
2.6
3.4
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
15
195
0.75
0.44
1.5
1.3
iu/ml
33.0
40.7
—
6
72
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
5
32
1.58
0.42
1.0
1.2
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
5
32
1.58
0.42
1.6
1.7
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
123
1171
1.19
0.41
21.1
14.9
mg/l
36.5
22.0
3.73
107
922
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
53
473
1.18
0.40
3.9
3.1
ng/l
4820.2
1832.0
0.43
43
404
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
5
35
1.44
0.39
1.4
1.8
u/l
27.8
37.8
—
5
29
(3021960) Folate [Moles/volume] in Serum or Plasma
41
358
1.19
0.39
1.3
1.6
nmol/l
21.4
22.7
0.17
34
302
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
0
19
0.00
0.39
0.0
1.3
—
68.0
—
0
7
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
9
67
1.36
0.39
3.4
3.5
mmol/l
25.4
25.8
—
9
67
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
6
41
1.48
0.36
2.3
1.6
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
51
565
0.86
0.36
2.3
2.4
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
6
43
1.41
0.35
3.5
3.2
mmol/l
7.9
7.3
—
6
43
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
13
100
1.33
0.35
2.9
2.7
mmol/l
1.2
1.2
0.00
13
84
(3008037) Lactate [Moles/volume] in Venous blood
6
46
1.32
0.33
3.5
3.1
mmol/l
1.5
1.5
—
6
46
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
110
1151
0.87
0.33
4.7
5.3
mmol/l
2.7
2.6
0.18
96
1033
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
68
627
1.14
0.33
2.6
2.7
u/l
76.4
42.1
0.75
60
573
(40761536) Microorganisms panel - Urine sediment
7
96
0.72
0.32
10.0
4.0
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
15
121
1.26
0.29
1.4
1.7
ug/g
69.5
165.3
—
10
92
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
15
183
0.80
0.29
1.3
1.3
u/ml
8.8
11.1
—
8
66
(3026493) Urate [Moles/volume] in Serum or Plasma
30
263
1.17
0.28
2.4
2.2
umol/l
28602.3
13121.1
0.23
22
218
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
30
264
1.17
0.27
1.7
1.7
mg/l
3.3
1.5
0.54
24
203
(4010399)
9
72
1.26
0.26
1.1
1.3
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
11
137
0.79
0.25
1.2
1.4
—
—
—
0
0
(3013512) EKG study
41
373
1.13
0.24
4.3
4.3
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
93
887
1.11
0.24
4.3
4.3
mm/h
21.2
15.2
2.36
82
798
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3011648) Oxygen content in Venous blood
0
10
0.00
0.21
0.0
1.8
—
11.1
—
0
10
(3000093) Morphology [Interpretation] in Blood Narrative
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
0
10
0.00
0.21
0.0
4.2
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(4062490)
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3019225) pH of Specimen
13
108
1.22
0.21
4.5
3.0
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
26
290
0.88
0.20
5.3
4.6
ng/l
53.0
82.3
0.49
21
256
(3004588) Protein electrophoresis panel - Serum or Plasma
11
90
1.24
0.19
2.2
1.3
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
68
645
1.09
0.18
7.6
6.3
estimate
0.0
0.0
0.00
11
95
(3035350) Ketones [Presence] in Urine by Test strip
67
636
1.09
0.18
5.4
4.6
estimate
0.0
0.0
0.00
11
102
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
11
131
0.83
0.17
3.5
4.5
%
37.2
33.3
—
5
83
(3004716) Salmonella sp identified in Stool by Organism specific culture
7
62
1.13
0.17
1.3
1.3
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
30
328
0.90
0.17
3.5
3.6
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
107
1037
1.09
0.17
22.1
14.3
ml/min/173m2
69.7
68.9
0.13
91
823
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
108
1112
0.92
0.17
4.1
4.7
mmol/l
4.7
4.6
0.34
93
1003
(3009261) Glucose [Presence] in Urine by Test strip
68
648
1.08
0.16
5.5
4.5
estimate
0.0
0.0
0.50
11
100
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
59
559
1.09
0.16
3.8
4.2
ng/l
28.9
97.0
0.60
46
407
(3000330) Specific gravity of Urine by Test strip
8
98
0.81
0.14
6.6
4.1
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
122
1194
1.08
0.13
19.5
14.5
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
105
1024
1.07
0.12
25.4
17.1
%
37.3
38.0
0.28
66
632
(3009508) Creatinine [Moles/volume] in Urine
34
362
0.92
0.12
4.0
2.8
mmol/l
5.5
5.9
0.39
25
293
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
107
1094
0.94
0.11
4.0
4.6
mmol/l
1.6
1.6
0.03
90
984
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
47
493
0.94
0.11
7.0
5.0
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
34
361
0.93
0.11
3.8
2.9
mg/l
3058.2
216.2
0.72
22
212
(3020682) Albumin/Creatinine [Ratio] in Urine
37
389
0.94
0.09
5.2
3.5
mg/mmol
10.4
4.9
0.50
22
233
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
5
60
0.83
0.08
1.0
1.1
—
119.7
—
0
17
(3023103) Potassium [Moles/volume] in Serum or Plasma
125
1233
1.05
0.07
26.6
18.6
mmol/l
4.0
4.0
0.30
120
1190
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
114
1157
0.95
0.07
4.7
4.9
mmol/l
6.1
6.1
0.05
97
1032
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
9
88
1.02
0.07
1.9
1.5
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
8
92
0.86
0.07
1.5
1.6
—
—
—
0
0
(3022145) Colonoscopy Study observation
11
102
1.08
0.03
1.1
1.2
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
110
1110
0.97
0.03
6.4
6.3
mmol/mol
41.0
41.1
0.02
91
1016
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
14
148
0.94
0.02
4.6
3.7
ng/l
787.9
314.7
0.96
14
138
(40760892) CBC W Ordered Manual Differential panel - Blood
22
226
0.97
0.00
4.1
3.7
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
126
1266
0.98
0.00
32.3
21.5
e9/l
8.3
6.8
0.82
120
1220
(3026361) Erythrocytes [#/volume] in Blood
126
1266
0.98
0.00
32.2
21.5
e12/l
4.1
4.3
3.56
120
1216
(3029937) Albumin [Presence] in Urine by Test strip
33
331
1.00
0.00
6.9
5.0
estimate
0.0
0.0
—
10
96
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
122
1219
1.00
0.00
12.5
8.9
u/l
22.5
21.2
0.30
117
1162
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
105
1049
1.00
0.00
3.6
4.1
mmol/l
1.3
1.2
0.77
88
929
(3020564) Creatinine [Moles/volume] in Serum or Plasma
122
1223
0.99
0.00
25.8
17.3
umol/l
81.3
75.3
0.86
122
1223
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
112
1117
1.01
0.00
5.1
5.2
mu/l
1.9
2.0
0.16
99
1011
(3041096) Erythrocytes [Presence] in Urine by Automated
34
338
1.01
0.00
5.6
4.3
—
—
—
0
0
(3044889) 12 lead EKG panel
85
854
0.99
0.00
4.4
4.1
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
5
0.00
0.00
0.0
1.4
—
6.2
—
0
5
(3027008) Opiates [Presence] in Urine
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(4015189)
0
5
0.00
0.00
0.0
5.2
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
917.4
—
0
5
(3000764) Benzodiazepines [Presence] in Urine
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(4027681)
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004451) EKG impression Narrative
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum
0
5
0.00
0.00
0.0
1.4
—
34.7
—
0
5
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
8
79
1.01
0.00
2.5
2.1
%
0.9
1.0
—
8
79
(3029075) Extractable nuclear Ab panel - Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
0
5
0.00
0.00
0.0
4.2
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
31
310
1.00
0.00
1.4
1.7
pmol/l
397.1
480.9
1.16
22
252
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
0
6
0.00
0.00
0.0
2.3
—
1.2
—
0
6
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
7
71
0.99
0.00
1.1
1.4
—
51.8
—
0
5
(3029634) Reagin Ab [Titer] in Serum by VDRL
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024263) Appearance of Synovial fluid
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
5.1
—
0
6
(3016650) Hepatitis A virus Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
6
67
0.89
0.00
1.2
1.3
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
7
71
0.99
0.00
1.0
1.3
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.0
—
414.0
—
0
9
(3027944) Amphetamines [Presence] in Urine
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
0
8
0.00
0.00
0.0
1.9
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
6
61
0.98
0.00
3.8
1.6
g/l
10.4
10.4
—
6
56
(3014271) Vancomycin [Susceptibility]
0
9
0.00
0.00
0.0
2.7
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.3
—
111.6
—
0
6
(44806420)
0
8
0.00
0.00
0.0
2.1
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
6
60
1.00
0.00
7.5
4.7
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: C3_UTERUS_NAS_EXALLC – Malignant neoplasm of uterus, part unspecified, excluding all cancers (controls excluding all cancers)

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).